Patient-reported outcome measures in urology
Authors:
- Gopal L. NarangGNGopal L. Narang
- Stephanie C. PannellSPStephanie C. Pannell
- Aaron A. LavianaALAaron A. Laviana
- Kathy H.Y. HuenKHKathy H.Y. Huen
- Jason IzardJIJason Izard
- Angela B. SmithASAngela B. Smith
- Jonathan BergmanJBJonathan Bergman
- 1 July 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 27 (4) , 366-374
Abstract
Many urologic treatments have similar clinical outcomes, necessitating alternative methods to discriminate between options. Patient-reported outcome measures (PROMs) have become the new standard for evaluating the patient experience, and their use has drastically increased over the past decade. The purpose of this review is to discuss the status of PROMs in urology, highlight commonly used tools and address their future direction. An increasing number of urology-specific PROMs tools have been developed and validated. An increased focus on patient-centered care has provided an impetus for their rise in use. Implementation of PROMs has transitioned from being primarily descriptive in nature to producing actionable findings. Many PROMs are now implemented in daily clinical practice. The future of PROMs will involve new instrument development, integration into clinical practice and the use of PROMs as performance measures. PROMs are effective tools for characterizing symptom burden and health-related quality of life. With increasing clinical implementation, PROMs are playing an increasing role in patients’ clinical decision-making.Keywords
This publication has 81 references indexed in Scilit:
- A Systematic Review of Outcome Measures Use, Analytical Approaches, Reporting Methods, and Publication Volume by Year in Low Back Pain Trials Published between 1980 and 2012: Respice, adspice, et prospicePLOS ONE, 2016
- New Frontiers in Patient-Reported Outcomes: Adverse Event Reporting, Comparative Effectiveness, and Quality AssessmentAnnual Review of Medicine, 2014
- The Patient-Centered Outcomes Research Institute (PCORI) National Priorities for Research and Initial Research AgendaJAMA, 2012
- Reliability of adverse symptom event reporting by cliniciansQuality of Life Research, 2011
- Health care providers underestimate symptom intensities of cancer patients: A multicenter European studyHealth and Quality of Life Outcomes, 2010
- How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30Journal of Clinical Oncology, 2004
- The International Index of Erectile Function (IIEF): a state-of-the-science reviewInternational Journal Of Impotence Research, 2002
- Outcomes Research in Oncology: History, Conceptual Framework, and Trends in the LiteratureJNCI: Journal of the National Cancer Institute, 2000
- The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunctionUrology, 1997
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996